- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
UPDATED Apr 14, 2024
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
8 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AMPH | US$39.62 | -3.5% | -5.6% | US$1.9b | US$62.60 | PE14.1x | E19.7% | n/a | ||
BRKR | US$87.58 | -2.9% | 6.0% | US$12.1b | US$86.20 | PE28.2x | E2.5% | 0.2% | ||
PBYI | US$5.27 | -6.4% | 76.3% | US$254.1m | US$4.33 | PE11.8x | E-53.5% | n/a | ||
ELTP | US$0.14 | 0.9% | 356.8% | US$149.6m | n/a | PE9.6x | n/a | n/a | ||
BMY | US$48.28 | -5.5% | -31.6% | US$97.9b | US$56.28 | PE12.2x | E7.4% | 5.0% | ||
ZTS | US$149.98 | -9.5% | -14.1% | US$68.5b | US$219.87 | PE29.2x | E8.1% | 1.2% | ||
HALO | US$38.61 | -3.3% | 7.2% | US$4.9b | US$50.70 | PE17.4x | E20.7% | n/a | ||
MEDP | US$395.00 | -3.4% | 102.0% | US$12.2b | US$402.04 | PE43.3x | E14.7% | n/a |
Page 1 of 1